Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy: Annals of the new york academy of sciences

Annals of the New York Academy of Sciences

Volumn 1188, Issue , 2010, Pages 96-102

  Kehat, Izhak ^a   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac hypertrophy; ERKs; Mouse models

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE;

CONFERENCE PAPER; ENZYME SPECIFICITY; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 77649162900     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05088.x     Document Type: Conference Paper

References (24)

1. Ho, K.K., J.L. Pinsky, W.B. Kannel & D. Levy. 1993. The epidemiology of heart failure: the Framingham Study. J. Am. Coll. Cardiol. 22: 6A-13A.
2. Klein, L. et al. 2003. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am. J. Cardiol. 91: 18F-40F.
3. Bueno, O.F. & J.D. Molkentin. 2002. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91: 776-781.
4. Garrington, T.P. & G.L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell. Biol 11: 211-218. (Pubitemid 29164036) (Pubitemid 29164036)
5. Wellbrock, C., M. Karasarides & R. Marais. 2004. The RAF proteins take centre stage. Nat. Rev. Mol. Cell. Biol. 5: 875-885. (Pubitemid 39486539) (Pubitemid 39486539)
6. Lange-Carter, C.A., C.M. Pleiman, A.M. Gardner, et al. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315-319. (Pubitemid 23160137)
7. Shaul, Y.D. & R. Seger. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773: 1213-1226.
8. Alessi, D.R. et al. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13: 1610-1619. (Pubitemid 24114712)
9. Adachi, M., M. Fukuda & E. Nishida. 2000. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell Biol. 148: 849-856. (Pubitemid 30680934) (Pubitemid 30680934)
10. Liang, Q. et al. 2001. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol. Cell Biol. 21: 7460-7469. (Pubitemid 32953496) (Pubitemid 32953496)
11. Fjeld, C.C., A.E. Rice, Y. Kim, et al. 2000. Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase. J. Biol Chem. 275: 6749-6757. (Pubitemid 30146211) (Pubitemid 30146211)
12. Bueno, O.F. et al. 2000. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19: 6341-6350.
13. Purcell, N.H. et al. 2007. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl. Acad. Sci. USA 104: 14074-14079.
14. Molkentin, J.D. & J. Robbins. 2009. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J. Mol. Cell Cardiol. 46: 130-136.
15. Hunter, J.J., N. Tanaka, H.A. Rockman, et al. 1995. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J. Biol Chem. 270: 23173-23178.
16. Maillet, M. et al. 2008. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J. Biol. Chem. 283: 31246-31255.
17. Lorenz, K., J.P. Schmitt, E.M. Schmitteckert & M.J. Lohse. 2009. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15: 75-83.
18. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
19. Babu, G.J., M.J. Lalli, M.A. Sussman, et al. 2000. Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J. Mol. Cell Cardiol. 32: 1447-1457.
20. Zheng, C.F. & K.L. Guan. 1993. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases. J. Biol Chem. 268: 23933-23939. (Pubitemid 23335368)
21. Belanger, L.F. et al. 2003. Mek2 is dispensable for mouse growth and development. Mol. Cell Biol. 23: 4778-11787
22. Fischer, A.M., C.D. Katayama, G. Pages, et al. 2005. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23: 431-443.
23. Lips, D.J. et al. 2004. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109: 1938-1941.
24. Aries, A., P. Paradis, C. Lefebvre, et al. 2004. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl. Acad. Sci. USA 101: 6975-6980.